Lipocine (NASDAQ:LPCN) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 121.43 percent decrease over earnings of $0.14 per share from the same period last year.
First Republic Folds As Banking Crisis Claims Third Victim: JPMorgan To Buy Deposits, Assets
The First Republic Bank (NYSE:FRC) saga is winding to a close with the Federal Deposit Insurance Corporation confirming…
